These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17854240)

  • 1. Adherence to pharmacotherapy in bipolar disorder patients with and without co-occurring substance use disorders.
    Manwani SG; Szilagyi KA; Zablotsky B; Hennen J; Griffin ML; Weiss RD
    J Clin Psychiatry; 2007 Aug; 68(8):1172-6. PubMed ID: 17854240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The spectrum of substance abuse in bipolar disorder: reasons for use, sensation seeking and substance sensitivity.
    Bizzarri JV; Sbrana A; Rucci P; Ravani L; Massei GJ; Gonnelli C; Spagnolli S; Doria MR; Raimondi F; Endicott J; Dell'Osso L; Cassano GB
    Bipolar Disord; 2007 May; 9(3):213-20. PubMed ID: 17430295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
    Mazza M; Mandelli L; Di Nicola M; Harnic D; Catalano V; Tedeschi D; Martinotti G; Colombo R; Bria P; Serretti A; Janiri L
    J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depressive residual symptoms are associated with lower adherence to medication in bipolar patients without substance use disorder: results from the FACE-BD cohort.
    Belzeaux R; Correard N; Boyer L; Etain B; Loftus J; Bellivier F; Bougerol T; Courtet P; Gard S; Kahn JP; Passerieux C; Leboyer M; Henry C; Azorin JM;
    J Affect Disord; 2013 Dec; 151(3):1009-15. PubMed ID: 24051101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of short-term olanzapine in patients with bipolar I disorder, with or without comorbidity with substance use disorder.
    Sani G; Kotzalidis GD; Vöhringer P; Pucci D; Simonetti A; Manfredi G; Savoja V; Tamorri SM; Mazzarini L; Pacchiarotti I; Telesforo CL; Ferracuti S; Brugnoli R; Ambrosi E; Caloro M; Del Casale A; Koukopoulos AE; Vergne DE; Girardi P; Ghaemi SN
    J Clin Psychopharmacol; 2013 Apr; 33(2):231-5. PubMed ID: 23422396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonadherence with mood stabilizers: prevalence and predictors.
    Scott J; Pope M
    J Clin Psychiatry; 2002 May; 63(5):384-90. PubMed ID: 12019661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with medication adherence in African American and white patients with bipolar disorder.
    Fleck DE; Keck PE; Corey KB; Strakowski SM
    J Clin Psychiatry; 2005 May; 66(5):646-52. PubMed ID: 15889954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of adherence to psychopharmacological and psychosocial treatment in bipolar I or II disorders - an 18-month prospective study.
    Arvilommi P; Suominen K; Mantere O; Leppämäki S; Valtonen H; Isometsä E
    J Affect Disord; 2014 Feb; 155():110-7. PubMed ID: 24262639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment adherence with antipsychotic medications in bipolar disorder.
    Sajatovic M; Valenstein M; Blow FC; Ganoczy D; Ignacio RV
    Bipolar Disord; 2006 Jun; 8(3):232-41. PubMed ID: 16696824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does recovery from substance use disorder matter in patients with bipolar disorder?
    Weiss RD; Ostacher MJ; Otto MW; Calabrese JR; Fossey M; Wisniewski SR; Bowden CL; Nierenberg AA; Pollack MH; Salloum IM; Simon NM; Thase ME; Sachs GS;
    J Clin Psychiatry; 2005 Jun; 66(6):730-5; quiz 808-9. PubMed ID: 15960566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzodiazepine prescription practices and substance abuse in persons with severe mental illness.
    Clark RE; Xie H; Brunette MF
    J Clin Psychiatry; 2004 Feb; 65(2):151-5. PubMed ID: 15003066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Achieving remission and recovery in bipolar disorder.
    Colom F
    J Clin Psychiatry; 2010 Nov; 71(11):e32. PubMed ID: 21114945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Atypical Antipsychotics in Bipolar Disorder With Comorbid Substance Dependence: A Systematic Review.
    Sepede G; Lorusso M; Spano MC; Di Nanno P; Di Iorio G; Di Giannantonio M
    Clin Neuropharmacol; 2018; 41(5):181-191. PubMed ID: 30036197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of psychodrug prescription patterns in patients diagnosed with bipolar disorder and addiction.
    Barral D; Barral F; Cruz N; Molina JD; Sánchez V; Rosique T
    Actas Esp Psiquiatr; 2016 Nov; 44(6):222-30. PubMed ID: 27906413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication adherence and attitudes in patients with bipolar disorder and current versus past substance use disorder.
    Teter CJ; Falone AE; Bakaian AM; Tu C; Ongür D; Weiss RD
    Psychiatry Res; 2011 Dec; 190(2-3):253-8. PubMed ID: 21696830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-reported medication treatment adherence among veterans with bipolar disorder.
    Sajatovic M; Bauer MS; Kilbourne AM; Vertrees JE; Williford W
    Psychiatr Serv; 2006 Jan; 57(1):56-62. PubMed ID: 16399963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic.
    Sajatovic M; Ignacio RV; West JA; Cassidy KA; Safavi R; Kilbourne AM; Blow FC
    Compr Psychiatry; 2009; 50(2):100-7. PubMed ID: 19216885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age comparison of treatment adherence with antipsychotic medications among individuals with bipolar disorder.
    Sajatovic M; Blow FC; Kales HC; Valenstein M; Ganoczy D; Ignacio RV
    Int J Geriatr Psychiatry; 2007 Oct; 22(10):992-8. PubMed ID: 17323327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between concurrent psychotropic medications and self-reported adherence with taking a mood stabilizer in bipolar disorder.
    Bauer M; Glenn T; Grof P; Marsh W; Sagduyu K; Alda M; Murray G; Lewitzka U; Schmid R; Haack S; Whybrow PC
    Hum Psychopharmacol; 2010 Jan; 25(1):47-54. PubMed ID: 20033908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants.
    Ghaemi SN; Hsu DJ; Thase ME; Wisniewski SR; Nierenberg AA; Miyahara S; Sachs G
    Psychiatr Serv; 2006 May; 57(5):660-5. PubMed ID: 16675760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.